NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther.1981;30:239-245.
2.
SidoroffADunantAViboudC. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).Br J Dermatol.2007;157:989-996.
SulewskiRJJrBlyuminMKerdelFA. Acute generalized exanthematous pustulosis due to clindamycin. Dermatol Online J.2008;14:14.
5.
OtsukaATanizakiHOkamotoNTakagakiK.A case of acute generalized exanthematous pustulosis caused by lincomycin. J Dermatol. 2005;32:929-930.
6.
BarbaudA. Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep.2014;14:442.
7.
BarbaudAColletEMilpiedB. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168:555-562.
